Skip to main content

ZURICH HEART HOUSE

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the "European Heart Journal" and as the seat of the "Foundation for Cardiovascular Research", the Zurich Heart House is one of the most important cardiology research and education centres in Europe.

The Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

ZHH News

Tätigeitsbericht 2023

KREISLAUF FORSCHUNG ZURICH HEART HOUSE TÄTIGKEITSBERICHT 2022

Um den Bericht zu lesen und herunterzuladen, klicken Sie HIER!

PCHFOnlineM5

NEW: An Updated version of Module 5 (2nd Edition) of the PCHF London online is now available!

The Zurich Heart House, known throughout the world for its excellence in providing postgraduate courses in heart failure, has created the perfect course for you: the online Postgraduate Course in Heart Failure London (PCHF London online)!

CardUp2022

NEW: The replay videos from the Cardiology Update London 2022 meeting are now Available on Demand!

Did you miss this year's Cardiology Update London? The video recordings of the very successful meeting are now available on demand

Purchase the videos now!

Cardiology News

WeinSchokoladeKaffee

Wein, Schokolade und Kaffee: Wie gesund sind sie?

Das Leben besteht aus mehr als nur Arbeit, auch für engagierte Kardiolog:innen, Gastroenterolog:innen und Ernährungsmediziner:innen. So geniessen wir alle – und auch die Patient:innen – gerne Wein, Getränke, Süssigkeiten und Kaffee, allein oder in Gesellschaft. Sind das verbotene Freuden oder schützen sie gar vor Krankheit und Tod?

Lesen Sie den ganzen Artikel (gastroMAG, N°2, Mai 2023)

Sex&Cardiovascular

Sex and cardiovascular disease

For many years, cardiovascular disease was considered a male disease. Consequently, common data of registries, clinical trials and the like, were all reported for the entire patient population and only until recently has it become mandatory to report data on males and females separately.

Read full article (Cardiovasc Med 2023;26(3):67)

Initalbp

Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes

Cardiovascular (CV) diseases remain the leading cause of death globally, of which the majority are due to chronic and acute coronary syndromes (ACS).

Read full article (European Heart Journal: Acute Cardiovascular Care (2023) 00, 1–14)